GLP1R and obesity due to melanocortin 4 receptor deficiency: Furthermore, baseline BMI differences between cohorts, despite matching, point to possible confounders in treatment selection that could impact outcomes, as obesity and adiposity distribution might influence response to GLP‐1 RAs.